The risk of an elevated intraocular pressure after treatment with topical corticosteroids in the periocular region

one Skov0 个研究点目标入组 42 人开始时间: 2020年2月11日最近更新: 2023年10月30日

试验速览

暂无简介。

•Age: 18-75 years
•BMI: <30 kg/m2
•Signed consent
•Only relevant for patients with atopic dermatitis:
•Known atopic dermatitis, assessed by EASI (Eczema Area and Severity Index) and TLSS (Target Lesion Severity Score)
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 42
•F.1.3 Elderly (>=65 years) no
•F.1.3.1 Number of subjects for this age range

•Medical history of an eye disease that requires treatment with corticosteroids, including inflammatory eye diseases, such as iritis.
•Treatment with previous drugs that contains corticosteroid (within the last 4 weeks).
•Allergy towards the ingredients in the drugs administered during the trial.
•Diagnosed diseases that may affect or can be affected by the trial/treatment. These include untreated infections, acne vulgaris, rosacea, perioral dermatitis and malignant/premalignant lesions.

发起方

one Skov